Howell Kelli Mari
SEC CIK 1734485 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | EVP, Clinical Strategies | 540.1K | — | — | 4 | 2021-08-05 | 2022-08-05 |
Most active insiders at ATEC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pelizzon David R | Dir, 10% | — | $20.57M |
| 2 | Pritzker Jennifer N. | 10% | — | $15.65M |
| 3 | Squadron Capital Holdings LLC | 10% | — | $15.65M |
| 4 | Squadron Capital LLC | 10% | — | $15.65M |
| 5 | Miles Patrick | CEO, Dir | $1.01M | $7.60M |
| 6 | Hunsaker Craig E | EVP, PEOPLE, CULTURE | — | $4.66M |
| 7 | Sponsel David | EVP, SALES | — | $4.47M |
| 8 | Lish Scott | COO | — | $4.32M |
| 9 | Rydin Jeffrey P | Dir | — | $3.86M |
| 10 | Marshall Tyson Eliot | GC, CORP. SEC | — | $3.05M |
Howell Kelli Mari made no open-market trades at ATEC in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-09 | 2022-08-05 | ATEC | Alphatec Holdings, Inc. | Howell Kelli Mari | EVP, CLINICAL STRATEGIES | F - Tax | $8.03 | -6,050 | 540.1K | -1% | -$48.6K | |
| 2022-03-22 | 2022-03-18 | ATEC | Alphatec Holdings, Inc. | Howell Kelli Mari | EVP, Clinical Strategies | F - Tax | $10.94 | -2,940 | 544.1K | -0.5% | -$32.2K | |
| M | 2022-02-28 | 2022-02-24 | ATEC | Alphatec Holdings, Inc. | Howell Kelli Mari | EVP, Clinical Strategies | A - Grant | $0.00 | +55.7K | 516.4K | +12% | $0 |
| 2021-08-09 | 2021-08-05 | ATEC | Alphatec Holdings, Inc. | Howell Kelli Mari | EVP, Clinical Strategies | F - Tax | $15.23 | -6,050 | 491.4K | -1% | -$92.1K |
Purchase Sale Sale after option exercise All abbreviations